Bio-Rad Laboratories, Inc. Announces Executive Changes, Effective January 4, 2022
October 05, 2021 at 02:16 am IST
Share
On September 28, 2021, Annette Tumolo, the Executive Vice President, President, Life Science Grboup, of Bio-RadLaboratories, Inc. and a named executive officer of the Company, informed the Company of her intention to retire from her position at the Company, effective January 4, 2022. Ms. Tumolo’s retirement concludes almost thirty-three years of service to the Company. The Company is undertaking a search for a successor.
Bio-Rad Laboratories, Inc. is specialized in the development, manufacturing and marketing of products used in life sciences research, clinical diagnostics and analytical chemistry. Net sales break down by activity as follows:
- manufacture of clinical diagnostic tests and automated test systems (51.8%). The group also offers test kits, quality control systems and related IT systems;
- manufacture of reagents, equipment and instruments for biological research (48.1%): for the separation, identification and purification of chemical and biological substances (proteins, nucleic acids, bacteria, etc.) for the proteomics, genomics research, biopharmaceuticals, cell biology and food safety markets;
- other (0.1%): in particular, manufacturing of analytical instruments.
At the end of 2022, the Group has 16 production sites in the United States (5), Germany (3), France (2), China (2), Poland, the United Kingdom, Switzerland and Singapore.
Net sales are distributed geographically as follows: the United States (41.2%), Europe (30.4%), Asia (22.8%) and other (5.6%).